Results 11 to 20 of about 1,079,743 (210)

Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections

BMC Pulmonary Medicine, 2022
Background Post-COVID-19 syndrome is characterized by diverse symptoms and abnormalities that persist beyond 12 weeks from the onset of acute COVID-19.
Dulce González-Islas, Carlos Sánchez-Moreno, Arturo Orea-Tejeda, Samantha Hernández-López, Fernanda Salgado-Fernández, Candace Keirns-Davis, Susana Galicia-Amor, Esperanza Trejo-Mellado, Laura Gochicoa-Rangel, Armando Castorena-Maldonado   +9 more
doaj   +1 more source

Pulmonary rehabilitation for cystic fibrosis: A narrative review of current literature

Monaldi Archives for Chest Disease, 2021
Pulmonary rehabilitation is a key component in cystic fibrosis care.  This review summarizes the recent evidence in the area of pulmonary rehabilitation for cystic fibrosis in the form of questions and answers regarding interventions, indications ...
Evgenia I. Kalamara, Evangelos T. Ballas, Georgia Pitsiou, Guergana Petrova   +3 more
doaj   +1 more source

A patient who made an impact on how I practice: Severe leptospirosis presenting as ARDS in the ICU

Journal of Infection and Public Health, 2018
Severe leptospirosis can be a rare cause of acute respiratory distress syndrome (ARDS) and multiorgan failure. A patient who made an impact on how I practice was a case of severe leptospirosis (Weil’s disease) that presented as ARDS in the ICU ...
Evangelia S. Panagiotidou, Sofia V. Akritidou, Seraphim T. Kotoulas, Evdokia K. Sourla, Basilis G. Mpikos, Basilis P. Bagalas, Ioannis T. Stanopoulos, Katalin M. Fekete, Athanasia D. Pataka   +8 more
doaj   +1 more source

Endothelial dysfunction in COPD: a systematic review and meta-analysis of studies using different functional assessment methods

ERJ Open Research, 2021
Background Cardiovascular disease is a major cause of morbidity and mortality in COPD. Endothelial dysfunction is suggested to be one of the pathogenetic mechanisms involved.
Marieta P. Theodorakopoulou, Maria Eleni Alexandrou, Dimitra Rafailia Bakaloudi, Georgia Pitsiou, Ioannis Stanopoulos, Theodoros Kontakiotis, Afroditi K. Boutou   +6 more
doaj   +1 more source

Role of cardiopulmonary exercise test in the prediction of hemodynamic impairment in patients with pulmonary arterial hypertension

Pulmonary Circulation, 2022
Periodic repetition of right heart catheterization (RHC) in pulmonary arterial hypertension (PAH) can be challenging. We evaluated the correlation between RHC and cardiopulmonary exercise test (CPET) aiming at CPET use as a potential noninvasive tool for
B. Pezzuto, R. Badagliacca, M. Muratori, S. Farina, M. Bussotti, M. Correale, A. Bonomi, C. Vignati, S. Sciomer, S. Papa, E. Palazzo Adriano, P. Agostoni   +11 more
doaj   +1 more source

Physiopathological rationale of using high-flow nasal therapy in the acute and chronic setting: A narrative review [PDF]

, 2019
Chronic lung disease and admissions due to acute respiratory failure (ARF) are becoming increasingly common. Consequently, there is a growing focus on optimizing respiratory support, particularly non-invasive respiratory support, to manage these ...
Cortegiani A., Gregoretti C., Spoletini G.   +2 more
core   +1 more source

Management of Mechanical Ventilation in Decompensated Heart Failure. [PDF]

, 2016
Mechanical ventilation (MV) is a life-saving intervention for respiratory failure, including decompensated congestive heart failure. MV can reduce ventricular preload and afterload, decrease extra-vascular lung water, and decrease the work of breathing ...
Adams, Jason Y, Bradley, Laura A, Dempsey, Timothy M, Kuhn, Brooks T, Puro, Alana C   +4 more
core   +4 more sources

Acute Effects of a Heat-Not-Burn Tobacco Product on Pulmonary Function

Medicina, 2020
Background and objectives: During the last decade, conventional tobacco smoking is experiencing a decline and new smoking products have been introduced. IQOS (“I-Quit-Ordinary-Smoking”) is a type of “heat-not-burn” (HNB) tobacco product.
Athanasia Pataka, Seraphim Kotoulas, Evangelos Chatzopoulos, Ioanna Grigoriou, Konstantinos Sapalidis, Christoforos Kosmidis, Anastasios Vagionas, Εleni-Isidora Perdikouri, Konstantinos Drevelegas, Paul Zarogoulidis, Paraskevi Argyropoulou   +10 more
doaj   +1 more source

Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in acute lung injury to reduce pulmonary dysfunction (HARP-2) trial : study protocol for a randomized controlled trial [PDF]

, 2012
Acute lung injury (ALI) is a common devastating clinical syndrome characterized by life-threatening respiratory failure requiring mechanical ventilation and multiple organ failure.
A Mercat, AM Cheung, C Brun-Buisson, C Rossi, Cecilia M O’Kane, Christine McNally, Daniel F McAuley, DJ Kor, Excellence NIfHaC, F Gao Smith, Gavin D Perkins, GD Rubenfeld, GR Bernard, Grainne Crealey, Irish Critical Care Trials Group, John G Laffey, KF Schulz, LA Curtis, Lynn Murphy, M Shyamsundar, MA Matthay, Mark Cross, Michael Stevenson, MS Herridge, RG Brower, S Harvey, SE Erickson, T Craig, The ARDS Network investigators, The EuroQol Group, TR Craig, TW Felton   +31 more
core   +1 more source

Respiratory failure in the child [PDF]

Jornal de Pediatria, 1998
OBJECTIVE: To describe the main physiopathologic mechanism of the respiratory failure in the child, as well as to discuss some aspects of the differential diagnosis and treatment. SOURCE OF DATA: The main national and international textbooks and articles about respiratory failure in the child were used as sources of data for this research.
J P, Piva, P C, Garcia, J C, Santana, S S, Barreto   +3 more
openaire   +2 more sources